Schedule 13D ownership disclosure
BIOTIME INC
Security class unavailable · CUSIP: 09066L105
Event date: 2014-05-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-14-002815
- Form type
- SC 13D
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- May 05, 2014
- Reporting period
- May 01, 2014
- Description
- Schedule 13D beneficial ownership